Seer, Inc. (SEER) is a Biotechnology company in the Healthcare sector, currently trading at $1.96. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Valuation: SEER trades at a trailing Price-to-Earnings (P/E) of -1.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.47.
Financials: revenue is $17M, +4.7%/yr average growth. Net income is $74M (loss), growing at +5.8%/yr. Net profit margin is -444% (negative). Gross margin is 51.1% (+5.2 pp trend).
Balance sheet: total debt is $24M against $259M equity (Debt-to-Equity (D/E) ratio 0.09, conservative). Current ratio is 12.84 (strong liquidity). Debt-to-assets is 8%. Total assets: $296M.
Analyst outlook: 1 / 4 analysts rate SEER as buy (25%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 55/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 50/100 (Partial), Future 20/100 (Fail), Income 10/100 (Fail).
